This week, Rachael and Natalie chat about the recent FDA approval of a new CRISPR gene editing technology for sickle cell disease. Tune in to hear a discussion of the patient narratives that are often overlooked in the biotech discourse, and the exorbitant costs of healthcare in the US.

Email us at [email protected] and follow us @women_in_science_pdx on Instagram, Twitter, and Facebook.